MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$604K
EPS
-$0.01
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Sales - devices and disposables
0
0
559*
60
Cost of goods sold
0
0
102*
25
Gross profit
0
0
457
35
Research and development
34
45
126
136
Sales and marketing
23
23
23
22
General and administrative
423
451
1,018
362
Gain on remeasurement of deferred compensation conversion liability
2
217
-
-
Total operating expenses
478
302
1,167
520
Loss from operations
-478
-302
-710
-485
Interest expense
136
151
184
129
Interest income
-
-
0*
0
Inducement charge for warrants issued
0
78
-
-
Change in fair value of derivative liability
9
13
76*
-37
Gain from forgiveness of debt
0
3
51*
15
Loss on extinguishment of debt
0
0
-836*
-106
Other income
0
15
165*
0
Total other income (expense)
-127
-198
-729
-257
Loss before income taxes
-605
-500
-1,216
-742
Provision for income taxes
0
0
0
0
Net loss
-605
-500
-1,216
-742
Deemed dividend
-
510
-
-
Deemed dividend for warrant exchanges
0
-
-
-
Preferred stock dividends
-
3
26
43
Preferred stock dividends adjustment
-1
-
-
-
Net loss attributable to common stockholders
-604
-1,013
-1,242
-785
Basic EPS
-0.01
-0.01
-0.017
-0.01
Diluted EPS
-0.01
-0.01
-0.015
-0.01
Basic Average Shares
96,536,000
88,836,000
75,139,000
81,689,000
Diluted Average Shares
96,536,000
88,836,000
84,838,000
81,689,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
attributable to common...
-$604K
(29.44%↑ Y/Y)
Preferred stock dividends
adjustment
-$1K
Net loss
-$605K
(25.40%↑ Y/Y)
Loss before income
taxes
-$605K
(25.40%↑ Y/Y)
Loss from operations
-$478K
(37.35%↑ Y/Y)
Total other income
(expense)
-$127K
(-298.44%↓ Y/Y)
Change in fair value of
derivative liability
$9K
(-70.00%↓ Y/Y)
Total operating
expenses
$478K
(-43.23%↓ Y/Y)
Interest expense
$136K
(-13.38%↓ Y/Y)
Gain on
remeasurement of deferred...
$2K
General and
administrative
$423K
(-35.71%↓ Y/Y)
Research and development
$34K
(-74.44%↓ Y/Y)
Sales and marketing
$23K
(-54.90%↓ Y/Y)
Buy us a coffee
GUIDED THERAPEUTICS INC (GTHP)
GUIDED THERAPEUTICS INC (GTHP)